{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,1,25]],"date-time":"2025-01-25T05:09:39Z","timestamp":1737781779563,"version":"3.33.0"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,11,26]],"date-time":"2024-11-26T00:00:00Z","timestamp":1732579200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,11,26]],"date-time":"2024-11-26T00:00:00Z","timestamp":1732579200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1007\/s10620-024-08697-y","type":"journal-article","created":{"date-parts":[[2024,11,26]],"date-time":"2024-11-26T09:24:02Z","timestamp":1732613042000},"page":"111-114","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Alpha Guy? No, Alpha Gal\u2014Important to Remember in Patients with IBD in Endemic Areas"],"prefix":"10.1007","volume":"70","author":[{"given":"Alicia","family":"Muratore","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edward L.","family":"Barnes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Millie D.","family":"Long","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hans H.","family":"Herfarth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah","family":"McGill","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,11,26]]},"reference":[{"key":"8697_CR1","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1016\/j.cgh.2022.12.035","volume":"21","author":"SK McGill","year":"2023","unstructured":"McGill SK, Hashash JG, Platts-Mills TA. AGA clinical practice update on Alpha-Gal syndrome for the GI clinician: commentary. Clin Gastroenterol Hepatol 2023;21:891\u2013896.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"8697_CR2","doi-asserted-by":"publisher","first-page":"822","DOI":"10.14309\/ajg.0000000000001765","volume":"117","author":"SK McGill","year":"2022","unstructured":"McGill SK, Richards RD Jr, Commins SP. Suddenly steakless: a gastroenterologist\u2019s guide to managing alpha-gal allergy. Am J Gastroenterol 2022;117:822\u2013826.","journal-title":"Am J Gastroenterol"},{"key":"8697_CR3","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.jaci.2014.01.024","volume":"134","author":"SP Commins","year":"2014","unstructured":"Commins SP, James HR, Stevens W et al. Delayed clinical and ex vivo response to mammalian meat in patients with IgE to galactose-alpha-1,3-galactose. J Allergy Clin Immunol 2014;134:108\u201315.","journal-title":"J Allergy Clin Immunol"},{"key":"8697_CR4","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1016\/j.jaci.2020.01.047","volume":"145","author":"TAE Platts-Mills","year":"2020","unstructured":"Platts-Mills TAE, Commins SP, Biedermann T et al. On the cause and consequences of IgE to galactose-alpha-1,3-galactose: a report from the National institute of allergy and infectious diseases workshop on understanding IgE-mediated mammalian meat allergy. J Allergy Clin Immunol 2020;145:1061\u20131071.","journal-title":"J Allergy Clin Immunol"},{"key":"8697_CR5","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1111\/pai.12969","volume":"29","author":"T Mabelane","year":"2018","unstructured":"Mabelane T, Basera W, Botha M et al. Predictive values of alpha-gal IgE levels and alpha-gal IgE: total IgE ratio and oral food challenge-proven meat allergy in a population with a high prevalence of reported red meat allergy. Pediatr Allergy Immunol 2018;29:841\u2013849.","journal-title":"Pediatr Allergy Immunol"},{"key":"8697_CR6","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1097\/MCG.0000000000001827","volume":"58","author":"SK McGill","year":"2024","unstructured":"McGill SK, Levin ME, Shaheen NJ et al. Gastrointestinal-isolated distress is common in alpha-gal allergic patients on mammalian meat challenge. J Clin Gastroenterol 2024;58:80\u201384.","journal-title":"J Clin Gastroenterol"},{"key":"8697_CR7","doi-asserted-by":"publisher","first-page":"815","DOI":"10.15585\/mmwr.mm7230a2","volume":"72","author":"JM Thompson","year":"2023","unstructured":"Thompson JM, Carpenter A, Kersh GJ et al. Geographic distribution of suspected alpha-gal syndrome cases\u2014United States, January 2017-December 2022. MMWR Morb Mortal Wkly Rep 2023;72:815\u2013820.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"8697_CR8","doi-asserted-by":"publisher","first-page":"510","DOI":"10.5694\/j.1326-5377.2009.tb02533.x","volume":"190","author":"SA Van Nunen","year":"2009","unstructured":"Van Nunen SA, O\u2019Connor KS, Clarke LR, Boyle RX, Fernando SL. An association between tick bite reactions and red meat allergy in humans. Med J Aust 2009;190:510\u20131. https:\/\/doi.org\/10.5694\/j.1326-5377.2009.tb02533.x.","journal-title":"Med J Aust"},{"key":"8697_CR9","doi-asserted-by":"publisher","first-page":"783279","DOI":"10.3389\/falgy.2021.783279.PMID:35386980;PMCID:PMC8974695","volume":"16","author":"P Rom\u00e1n-Carrasco","year":"2021","unstructured":"Rom\u00e1n-Carrasco P, Hemmer W, Cabezas-Cruz A, Hod\u017ei\u0107 A, de la Fuente J, Swoboda I. The \u03b1-gal syndrome and potential mechanisms. Front Allergy 2021;16:783279. https:\/\/doi.org\/10.3389\/falgy.2021.783279.PMID:35386980;PMCID:PMC8974695.","journal-title":"Front Allergy"},{"key":"8697_CR10","doi-asserted-by":"publisher","unstructured":"Rom\u00e1n-Carrasco P, Lieder B, Somoza V, Ponce M, Sz\u00e9pfalusi Z, Martin D, Hemmer W, Swoboda I. Only \u03b1-gal bound to lipids, but not to proteins, is transported across enterocytes as an IgE-reactive molecule that can induce effector cell activation. Allergy 2019 Oct;74:1956\u20131968.[PMID: 31102539; PMCID: PMC6852507 https:\/\/doi.org\/10.1111\/all.13873]","DOI":"10.1111\/all.13873]"},{"key":"8697_CR11","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1016\/j.jaci.2022.02.030","volume":"150","author":"N Chakrapani","year":"2022","unstructured":"Chakrapani N, Fischer J, Swiontek K, Codreanu-Morel F, Hannachi F, Morisset M, Mugemana C, Bulaev D, Blank S, Bindslev-Jensen C, Biedermann T, Ollert M, Hilger C. \u03b1-gal present on both glycolipids and glycoproteins contributes to immune response in meat-allergic patients. J Allergy Clin Immunol. 2022;150:396-405.e11. https:\/\/doi.org\/10.1016\/j.jaci.2022.02.030.","journal-title":"J Allergy Clin Immunol."},{"key":"8697_CR12","doi-asserted-by":"publisher","first-page":"809","DOI":"10.15585\/mmwr.mm7230a1","volume":"72","author":"A Carpenter","year":"2023","unstructured":"Carpenter A, Drexler NA, McCormick DW et al. Health Care Provider Knowledge Regarding Alpha-gal Syndrome - United States, March-May 2022. MMWR Morb Mortal Wkly Rep 2023;72:809\u2013814.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"8697_CR13","unstructured":"Centers for Disease Control and Prevention: Products that May Contain Alpha-gal. https:\/\/www.cdc.gov\/ticks\/alpha-gal\/products.html. Access date Jan 22, 2024."},{"key":"8697_CR14","doi-asserted-by":"publisher","first-page":"e322","DOI":"10.1097\/PG9.0000000000000322","volume":"4","author":"E Gonzalez Polanco","year":"2023","unstructured":"Gonzalez Polanco E, Borowitz S. Delayed hypersensitivity reaction to infliximab due to mammalian meat allergy. JPGN Rep 2023;4:e322.","journal-title":"JPGN Rep"}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-024-08697-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10620-024-08697-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-024-08697-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,24]],"date-time":"2025-01-24T08:08:12Z","timestamp":1737706092000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10620-024-08697-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,26]]},"references-count":14,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["8697"],"URL":"https:\/\/doi.org\/10.1007\/s10620-024-08697-y","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"type":"print","value":"0163-2116"},{"type":"electronic","value":"1573-2568"}],"subject":[],"published":{"date-parts":[[2024,11,26]]},"assertion":[{"value":"20 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 October 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Edward L. Barnes has served as a consultant for AbbVie, Bristol-Meyers Squibb, Pfizer, Eli Lilly, Boomerang, Direct Biologics, and Target RWE.  Millie D. Long has served as a consultant for AbbVie, Pfizer, Takeda, Lilly, Bristol-Meyers Squibb, Target RWE, and Prometheus and has received research support from Pfizer, Takeda and Janssen.  Hans H. Herfarth has served as a consultant for Alivio, AMAG, BMS, Boehringer, ExeGi Pharma, Finch, Gilead, Janssen, Lycera, Merck, Otsuka, Pfizer, PureTech, Seres and research support from Allakos, Artizan, NovoNordisk, Pfizer Sarah McGill receives research support from: Revivicor, EvoEndo, Exact Sciences, Guardant Health, Clinical Genomics, Finch Therapeutics and Freenome Holdings. Alicia Muratore has no relevant disclosures for this work.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}